by

MYEBOGA Conversations Ep 9 The Shea Prueger Interview Expectations and Inclusion

Shea Prueger – Expectations & Inclusion

DIRECTOR, IBOGAINE ADMINISTRATOR – IBOGAINE REVELATIONS

Shea Prueger was introduced to ibogaine therapy by Eric Taub who she met while seeking treatment for suboxone addiction in 2010 while working as a full time fashion model. Following her own transformation, Shea began an apprenticeship under Lex Kogan at I Begin Again’s ibogaine facility in Guatemala and then Costa Rica, eventually taking over as director of the center.

Shea Prueger has ...

Continue Reading →
Cision
by

MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury

[ad_1]

This potential treatment opportunity was confirmed by the company’s bioinformatics platform, PsyCollage

VANCOUVER, BC, March 4, 2021 /PRNewswire/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”) a leader in developing technology to advance psychedelic-related treatments, is pleased to announce that the Company’s bioinformatics platform, PsyCollage, has identified opportunities for ibogaine to support neuroregenerative pathways that the Company believes could be pivotal in treating neuropathic pain and ...

Continue Reading →
by

Missouri Bill Would Add Psychedelics to ‘Right to Try’ Law

[ad_1]



Missouri Republican state Rep. Michael Davis last week introduced a measure to expand the state’s Right to Try statute to include Schedule I investigational drugs, including psilocybin, MDMA, LSD, mescaline, ibogaine, and DMT. The drugs would only be available after all other treatment options have been exhausted.

The Right to Try Law, enacted in the state in 2014, allows patients with terminal ...

Continue Reading →
Page 1 of 84 12345...»

Menu

Blog

Disclaimer

The information on this website is offered for informational use only. MYEBOGA specifically cautions against the use of iboga related products (i) in violation of the law, (ii) without appropriate professional guidance and monitoring, or (iii) without careful personal evaluation of potential risks and hazards. MYEBOGA specifically disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents of this website. This website does not promote ibogaine services in the R. O. Ireland.

About

This site is 100% voluntary and does not receive any form of payment from any of the providers listed here. In addition, this site does not engage in any way with the supply or manufacture of ibogaine or iboga related products or services. Information is offered for interest only and grew our of a desire to offer a service providing balanced information without any motive for profit.
UA-77446339-1